Vertex Pharmaceuticals ($VRTX)

Description

Vertex Pharmaceuticals develops and manufactures prescription medicines for people with serious diseases, focusing on therapies used by patients with cystic fibrosis, sickle cell disease, and genetic kidney disorders, and providing patient support programs.

Vertex Pharmaceuticals ($VRTX) is located in the Boston ecosystem.

Related

• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops gene-based medicines and CRISPR therapies for serious diseases, with programs spanning hemoglobinopathies,…
• Arbor BiotechnologiesArbor Biotechnologies develops genetic medicines using programmable DNA editors, with a focus on gene-editing therapies for central nervous…
• Metagenomi ($MGX)Metagenomi develops in vivo genome editing medicines, using tools discovered from environmental genetic material to correct genetic…
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious…
• Variant BioDevelops precision medicines using genomic data from people with exceptional health traits to identify genetically supported targets for…
• Tessera TherapeuticsTessera Therapeutics develops a Gene Writing platform to make permanent, targeted changes to the human genome and creates non-viral…
• Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…
• Ionis Pharmaceuticals ($IONS)Ionis Pharmaceuticals develops RNA- and DNA-targeted medicines for people living with serious diseases, applying genetics-driven science…
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…